Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

The Role of Red Blood Cell in Stroke-Related Hyperglycemia

$4.23M USD

Funder NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Recipient Organization Massachusetts General Hospital
Country United States
Start Date Aug 01, 2024
End Date May 31, 2029
Duration 1,764 days
Number of Grantees 3
Roles Principal Investigator; Co-Investigator
Data Source NIH (US)
Grant ID 10980717
Grant Description

Project Summary/Abstract Acute hyperglycemia following an ischemic stroke is a significant contributor to poor clinical outcome, even though it is temporary. While intensive insulin treatment can correct hyperglycemia, it does not necessarily improve patient outcome, suggesting the presence of early hyperglycemic injuries that are resistant to glucose

control. Red blood cells (RBCs), often overlooked in stroke research, are particularly vulnerable to hyperglycemia due to their exclusive reliance on glucose for energy and limited adaptability to metabolic disturbances in high glucose condition. Our pilot study has identified abnormal RBC indices in stroke patients

experiencing acute hyperglycemia, which, in turn, were predictive of poor stroke outcome. Further analyses revealed that acute hyperglycemia may initiate a shift in RBC glucose metabolism from the pentose phosphate pathway (PPP) towards the hexosamine pathway, potentially resulting in increased oxidative stress within

RBCs. Notably, these RBC changes were unresponsive to glucose normalization, but were able to impair the function of brain endothelial cells, indicating their novel role in acute hyperglycemic injury in ischemic stroke. In this multiple PI project, we aim to investigate the role of RBCs in stroke-related hyperglycemia through

translational research and mechanistic studies. We will characterize acute hyperglycemia-related RBC alterations in clinical stroke patients, with specific focus on RBC glucose metabolism and the consequent oxidative stress (Aim 1). We will then delve deeper into the mechanisms of RBC alterations in in vitro

hyperglycemic models and assess their impact on brain endothelial functions (Aim 2). Finally, we will validate our findings in a well-established acute hyperglycemic stroke mouse model and explore the potential of modifying RBCs to mitigate brain injury and improve stroke outcome in the context of acute hyperglycemia

(Aim 3). Successful completion of this project will yield a comprehensive understanding of the effects of acute hyperglycemia on RBCs and their consequences on vascular function, ultimately translating into enhanced clinical care and patient will-being.

All Grantees

Massachusetts General Hospital

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant